VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Coloplast A/S vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Coloplast A/S
COLOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Coloplast A/S's moat claims, evidence, and risks.
View COLOB analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Coloplast A/S leads (77 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Coloplast A/S has 5 segments (35.5% in Ostomy Care); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: Coloplast A/S has 7 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Coloplast A/S
Ostomy Care
Ostomy care products (bags, plates, supporting products)
Global
Healthcare providers and distributors; end-users are ostomy patients
Medical device manufacturer (disposable consumables)
35.5%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Coloplast A/S strengths
Sanofi strengths
Segment mix
Coloplast A/S segments
Full profile >Ostomy Care
Oligopoly
Continence Care
Oligopoly
Voice & Respiratory Care
Oligopoly
Wound & Tissue Repair
Competitive
Interventional Urology
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.